Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HALFMOON TomoTherapy (Helical ALtered Fractionation for iMplant partial OmissiON): implant-sparing post-mastectomy radiotherapy reshaping the clinical target volume in the reconstructed breast.
Leonardi MC, Spoto R, Miglietta E, Trivellato S, La Rocca E, Luraschi R, Grosso P, De Lorenzi F, Fodor C, Dicuonzo S, Dell'Acqua V, Gerardi MA, Morra A, Francia CM, Rietjens M, Galimberti VE, Veronesi P, Orecchia R, Cattani F, Jereczek-Fossa BA. Leonardi MC, et al. Among authors: la rocca e. J Cancer Res Clin Oncol. 2019 Jul;145(7):1887-1896. doi: 10.1007/s00432-019-02938-8. Epub 2019 May 29. J Cancer Res Clin Oncol. 2019. PMID: 31144158
Older age and comorbidity in breast cancer: is RT alone the new therapeutic frontier?
La Rocca E, Meneghini E, Lozza L, Fiorentino A, Vitullo A, Giandini C, Bonfantini F, Di Cosimo S, Gennaro M, Sant M, Pignoli E, Valdagni R, De Santis MC. La Rocca E, et al. J Cancer Res Clin Oncol. 2020 Jul;146(7):1791-1800. doi: 10.1007/s00432-020-03243-5. Epub 2020 May 13. J Cancer Res Clin Oncol. 2020. PMID: 32405744
Phase II prospective trial "Give Me Five" short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion: the impact of toxicity on quality of life (AIRC IG-13218).
Marvaso G, Gugliandolo SG, Bellerba F, Gandini S, Corrao G, Volpe S, Rojas DP, Riva G, Zerini D, Pepa M, Fodor CI, La Rocca E, Pricolo P, Alessi S, Petralia G, Mistretta FA, Cambria R, Cattani F, De Cobelli O, Orecchia R, Jereczek-Fossa BA. Marvaso G, et al. Among authors: la rocca e. Med Oncol. 2020 Jul 28;37(8):74. doi: 10.1007/s12032-020-01397-3. Med Oncol. 2020. PMID: 32725443 Clinical Trial.
Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up.
Kahler-Ribeiro-Fontana S, Pagan E, Magnoni F, Vicini E, Morigi C, Corso G, Intra M, Canegallo F, Ratini S, Leonardi MC, La Rocca E, Bagnardi V, Montagna E, Colleoni M, Viale G, Bottiglieri L, Grana CM, Biasuz JV, Veronesi P, Galimberti V. Kahler-Ribeiro-Fontana S, et al. Among authors: la rocca e. Eur J Surg Oncol. 2021 Apr;47(4):804-812. doi: 10.1016/j.ejso.2020.10.014. Epub 2020 Oct 15. Eur J Surg Oncol. 2021. PMID: 33092968
Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
De Rose F, De Santis MC, Meduri B, Franzese C, Franceschini D, Franco P, Pasinetti N, Lancellotta V, Giacobazzi P, La Rocca E, D'Angelo E, Lozza L, Livi L, Meattini I, Scorsetti M. De Rose F, et al. Among authors: la rocca e. J Cancer Res Clin Oncol. 2021 Jul;147(7):2069-2077. doi: 10.1007/s00432-020-03483-5. Epub 2021 Jan 2. J Cancer Res Clin Oncol. 2021. PMID: 33387035
95 results